Potent inhibitor for tumor promoter-mediated MAPK-signaling pathways, leading to Activator Protein 1 (AP-1) and Metalloproteinase (MMP)−9 activation by regulating cancer cell motility. This evidence concerns the gene FOS and neoplasm.